{"id":31182,"date":"2025-07-23T13:08:34","date_gmt":"2025-07-23T18:08:34","guid":{"rendered":"https:\/\/myeloma.ca\/?p=31182"},"modified":"2025-07-23T13:10:34","modified_gmt":"2025-07-23T18:10:34","slug":"lemploi-de-blenrep-belantamab-mafodotine-approuve-au-canada-dans-des-traitements-dassociation-chez-les-patients-atteints-de-myelome-multiple-recidivant-ou-refractaire","status":"publish","type":"post","link":"https:\/\/myeloma.ca\/fr\/2025\/07\/23\/lemploi-de-blenrep-belantamab-mafodotine-approuve-au-canada-dans-des-traitements-dassociation-chez-les-patients-atteints-de-myelome-multiple-recidivant-ou-refractaire\/","title":{"rendered":"L\u2019emploi de Blenrep (b\u00e9lantamab mafodotine) approuv\u00e9 au Canada dans des traitements d\u2019association chez les patients atteints de my\u00e9lome multiple r\u00e9cidivant ou r\u00e9fractaire"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">GSK a annonc\u00e9 aujourd\u2019hui que Sant\u00e9 Canada a approuv\u00e9 l\u2019emploi de\u00a0<em>Blenrep<\/em>\u00a0(b\u00e9lantamab mafodotine pour injection) en association avec le bort\u00e9zomib et la dexam\u00e9thasone, ou en association avec la pomalidomide et la dexam\u00e9thasone, pour le traitement des patients adultes atteints d\u2019un my\u00e9lome multiple r\u00e9cidivant ou r\u00e9fractaire ayant re\u00e7u au moins une ligne de traitement ant\u00e9rieur, y compris la l\u00e9nalidomide dans la seconde association.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/ca.gsk.com\/fr-ca\/medias\/communiques-de-presse\/lemploi-de-blenrep-belantamab-mafodotine-approuve-au-canada-dans-des-traitements-dassociation-chez-les-patients-atteints-de-myelome-multiple-recidivant-ou-refractaire\/\" data-type=\"link\" data-id=\"https:\/\/ca.gsk.com\/fr-ca\/medias\/communiques-de-presse\/lemploi-de-blenrep-belantamab-mafodotine-approuve-au-canada-dans-des-traitements-dassociation-chez-les-patients-atteints-de-myelome-multiple-recidivant-ou-refractaire\/\">Pour en savoir plus, cliquez ici<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>GSK a annonc\u00e9 aujourd\u2019hui que Sant\u00e9 Canada a approuv\u00e9 l\u2019emploi de\u00a0Blenrep\u00a0(b\u00e9lantamab mafodotine pour injection) en association avec le bort\u00e9zomib et la dexam\u00e9thasone, ou en association avec la pomalidomide et la dexam\u00e9thasone, pour le traitement des patients adultes atteints d\u2019un my\u00e9lome multiple r\u00e9cidivant ou r\u00e9fractaire ayant re\u00e7u au moins une ligne de traitement ant\u00e9rieur, y compris [&hellip;]<\/p>\n","protected":false},"author":10,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[88,53],"tags":[],"class_list":["post-31182","post","type-post","status-publish","format-standard","hentry","category-actualites","category-actualites-et-evenement"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts\/31182","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/comments?post=31182"}],"version-history":[{"count":1,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts\/31182\/revisions"}],"predecessor-version":[{"id":31183,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts\/31182\/revisions\/31183"}],"wp:attachment":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/media?parent=31182"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/categories?post=31182"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/tags?post=31182"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}